Back

Ticagrelor versus clopidogrel in primary percutaneous coronary intervention- Single center prospective study

13 April 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 3 - Coronary Artery Disease Coronary Artery Disease, Other EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Doctor Hossameldin Rasmy Mohamed

Sabah Al-Ahmad Cardiac Centre, Kuwait City (Kuwait)

35 More presentations in this session

Presentation thumbnail
Doctor M. Sladojevic (Novi Sad, RS)
Abstract
Presentation thumbnail
Doctor G. Sulo (Bergen, NO)
Abstract
Presentation thumbnail
Doctor K. Villelabeitia (Madrid, ES)
Abstract
Presentation thumbnail
Professor K. Kaminski (Bialystok, PL)
Abstract
Presentation thumbnail
Doctor H. Seyfert (Demmin, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Coronary Artery Disease

The Event

Event poster

EuroPrevent 2019

13 April 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Ticagrelor versus clopidogrel after fibrinolysis in STEMI: real-world analysis on reperfusion success
20 March 2026
thumbnail
Congress Session
Dual antiplatelet therapy titration after percutaneous coronary intervention: when to escalate, de-escalate, withdraw, and more
28 August 2023
thumbnail
Congress Presentation
Evaluating the safety and efficacy of ticagrelor vs. clopidogrel following percutaneous coronary intervention in chronic coronary disease
30 August 2025
thumbnail
Congress Presentation
Is there an inter-manufacturer difference in generic clopidogrel response?
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources